Related Experiment Video
Updated: Jun 25, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Recent experience with fungaemia: change in species distribution and azole resistance
Arunaloke Chakrabarti1, Shiv Sekhar Chatterjee, K L N Rao
1Departments of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012,India. arunaloke@hotmail.com
Abstract:
Owing to a rise in frequency and change in pattern of cases with fungaemia at our tertiary care centre, we conducted a prospective study for 4 months to understand the epidemiology and outcome of this infection. Detailed case histories including management protocol and outcomes were noted. Records of 140 cases with fungaemia (27.1% adult and 72.9% paediatric patients) were analysed. Although C. tropicalis was the most common yeast isolated, significantly higher isolation of C. guilliermondii (30.4%) and C. pelliculosa (17.6%) was noted in paediatric patients; and C. albicans (26.3%) and C. glabrata (10.5%) in adult patients. Rare species isolated included C. ustus (0.7%) and Trichosporon asahii (2.1%). Mortality was high (56.9% and 47.4%, respectively), in both groups of patients. Resistance to azoles (fluconazole, itraconazole, voriconazole) emerged in C. albicans (12.5-18.8%) and C. tropicalis (10.2-13.6%). Antifungal susceptibility testing report modified the therapy from fluconazole to amphotericin B in 8 patients; 5 survived. In conclusion, the study highlighted the rise of non-albicans Candida species in our hospital with differential distribution in paediatric and adult wards and emergence of azole resistance.
Related Concept Videos
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Candidiasis
Antifungal Agents
Cryptococcal Meningitis
Fungal Phylum Ascomycota

